Literature DB >> 17269560

Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.

Malcolm R Ogborn1, Evan Nitschmann, Neda Bankovic-Calic, Hope A Weiler, Harold M Aukema.   

Abstract

Flaxseed derivatives, including both oil and flax lignan, modify progression of renal injury in animal models, including Han:SPRD-cy polycystic kidney disease (PKD). Gender is a significant factor in the rates of progression of many forms of human renal disease, but the role of gender in the response to nutrition intervention in renal disease is unexplored. In this study, male and female Han:SPRD-cy rats or normal littermates were fed either corn oil (CO) or flax oil (FO) diets, with or without 20 mg/kg of the diet flax lignan secoisolaricinoresinol dyglycoside (SDG). Renal injury was assessed morphometrically and biochemically. Renal and hepatic PUFA composition was assessed by GC and renal PGE2 release by ELISA. FO preserved body weight in PKD males, with no effect in females. SDG reduced weight in both normal and PKD females. FO reduced proteinuria in both male and female PKD. FO reduced cystic change and renal inflammation in PKD males but reduced cystic change, fibrosis, renal inflammation, tissue lipid peroxides, and epithelial proliferation in PKD females. SDG reduced renal inflammation in all animals and lipid peroxides in PKD females. A strong interaction between SDG and FO was observed in renal FA composition of female kidneys only, suggesting increased conversion of C18 PUFA to C20 PUFA. FO reduced renal release of PGE2 in both genders. Gender influences the effects of flaxseed derivatives in Han:SPRD-cy rats. Gender-based responses to environmental factors, such as dietary lipid sources and micronutrients, may contribute to gender-based differences in disease progression rates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17269560     DOI: 10.1007/s11745-006-5064-z

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.646


  49 in total

1.  Role of EP2 and EP4 receptor-selective agonists of prostaglandin E(2) in acute and chronic kidney failure.

Authors:  S Vukicevic; P Simic; F Borovecki; L Grgurevic; D Rogic; I Orlic; W A Grasser; D D Thompson; V M Paralkar
Journal:  Kidney Int       Date:  2006-07-26       Impact factor: 10.612

Review 2.  Use of fish oil to treat patients with immunoglobulin a nephropathy.

Authors:  J V Donadio
Journal:  Am J Clin Nutr       Date:  2000-01       Impact factor: 7.045

3.  Autosomal dominant polycystic kidney disease in blacks: clinical course and effects of sickle-cell hemoglobin.

Authors:  J Yium; P Gabow; A Johnson; W Kimberling; M Martinez-Maldonado
Journal:  J Am Soc Nephrol       Date:  1994-03       Impact factor: 10.121

4.  Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease.

Authors:  Shizuko Nagao; Masatomo Kusaka; Kazuhiro Nishii; Tohru Marunouchi; Hiroki Kurahashi; Hisahide Takahashi; Jared Grantham
Journal:  J Am Soc Nephrol       Date:  2005-05-11       Impact factor: 10.121

5.  Dietary flax seed in prevention of hypercholesterolemic atherosclerosis.

Authors:  K Prasad
Journal:  Atherosclerosis       Date:  1997-07-11       Impact factor: 5.162

6.  Renal remodelling in dietary protein modified rat polycystic kidney disease.

Authors:  N Bankovic-Calic; A Eddy; S Sareen; M R Ogborn
Journal:  Pediatr Nephrol       Date:  1999-09       Impact factor: 3.714

7.  17beta -Estradiol modulates mechanical strain-induced MAPK activation in mesangial cells.

Authors:  Joan Krepinsky; Alistair J Ingram; Leighton James; Hao Ly; Kerri Thai; Daniel C Cattran; Judith A Miller; James W Scholey
Journal:  J Biol Chem       Date:  2002-01-02       Impact factor: 5.157

Review 8.  Acquired cystic kidney disease: the hormonal hypothesis.

Authors:  G Concolino; C Lubrano; M Ombres; A Santonati; G P Flammia; F Di Silverio
Journal:  Urology       Date:  1993-02       Impact factor: 2.649

9.  The effect of dietary flaxseed supplementation on organic anion and osmolyte content and excretion in rat polycystic kidney disease.

Authors:  M R Ogborn; E Nitschmann; N Bankovic-Calic; R Buist; J Peeling
Journal:  Biochem Cell Biol       Date:  1998       Impact factor: 3.626

10.  Flaxseed: a potential treatment for lupus nephritis.

Authors:  W F Clark; A Parbtani; M W Huff; E Spanner; H de Salis; I Chin-Yee; D J Philbrick; B J Holub
Journal:  Kidney Int       Date:  1995-08       Impact factor: 10.612

View more
  9 in total

1.  Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Lauren Pickel; Ioan-Andrei Iliuta; James Scholey; York Pei; Hoon-Ki Sung
Journal:  Adv Nutr       Date:  2021-11-10       Impact factor: 8.701

2.  Long term consumption of flaxseed enriched diet decreased ovarian cancer incidence and prostaglandin E₂in hens.

Authors:  Erfan Eilati; Janice M Bahr; Dale Buchanan Hales
Journal:  Gynecol Oncol       Date:  2013-05-23       Impact factor: 5.482

3.  Dietary conjugated linoleic acid renal benefits and possible toxicity vary with isomer, dose and gender in rat polycystic kidney disease.

Authors:  Malcolm R Ogborn; Evan Nitschmann; Aviva Goldberg; Neda Bankovic-Calic; Hope A Weiler; Harold M Aukema
Journal:  Lipids       Date:  2008-07-16       Impact factor: 1.880

4.  Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design.

Authors:  Yeong Rhee; Ardith Brunt
Journal:  Nutr J       Date:  2011-05-09       Impact factor: 3.271

5.  Feeding soy protein isolate and oils rich in omega-3 polyunsaturated fatty acids affected mineral balance, but not bone in a rat model of autosomal recessive polycystic kidney disease.

Authors:  Kaitlin H Maditz; Brenda J Smith; Matthew Miller; Chris Oldaker; Janet C Tou
Journal:  BMC Nephrol       Date:  2015-02-10       Impact factor: 2.388

6.  Dietary Flaxseed Oil Protects against Bleomycin-Induced Pulmonary Fibrosis in Rats.

Authors:  Joshua Lawrenz; Betty Herndon; Afrin Kamal; Aaron Mehrer; Daniel C Dim; Cletus Baidoo; David Gasper; Jonathan Nitz; Agostino Molteni; Richard C Baybutt
Journal:  Pulm Med       Date:  2012-08-08

7.  Flaxseed lignan complex administration in older human type 2 diabetics manages central obesity and prothrombosis-an invitation to further investigation into polypharmacy reduction.

Authors:  D E Barre; K A Mizier-Barre; E Stelmach; J Hobson; O Griscti; A Rudiuk; D Muthuthevar
Journal:  J Nutr Metab       Date:  2012-10-04

Review 8.  Potential protective properties of flax lignan secoisolariciresinol diglucoside.

Authors:  Muhammad Imran; Nazir Ahmad; Faqir Muhammad Anjum; Muhammad Kamran Khan; Zarina Mushtaq; Muhammad Nadeem; Shahzad Hussain
Journal:  Nutr J       Date:  2015-07-28       Impact factor: 3.271

9.  Lack of Benefit of Early Intervention with Dietary Flax and Fish Oil and Soy Protein in Orthologous Rodent Models of Human Hereditary Polycystic Kidney Disease.

Authors:  Tamio Yamaguchi; Jessay G Devassy; Md Monirujjaman; Melissa Gabbs; Harold M Aukema
Journal:  PLoS One       Date:  2016-05-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.